Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

844
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
844
Cancer Therapies02:49

Cancer Therapies

10.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.7K
Cancer Therapies02:49

Cancer Therapies

3.0K
3.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Impact of the COVID-19 Pandemic on Work-Life Integration of Physician Assistants in Oncology.

Journal of the advanced practitioner in oncology·2025
Same author

ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023.

ESMO open·2023
Same author

SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS).

Clinical cancer research : an official journal of the American Association for Cancer Research·2023
Same author

ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023.

JCO global oncology·2023
Same author

Moral Distress, Organizational Climate, and the Risk of Burnout Among Physician Assistants in Oncology.

JCO oncology practice·2023
Same author

Toward Team-Based Cancer Care in the United States: 6 Years Later.

JCO oncology practice·2022

Related Experiment Video

Updated: Apr 12, 2026

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

2.1K

Clinical oncology practice 2015: preparing for the future.

Michael P Kosty1, Anupama Kurup Acheson1, Eric D Tetzlaff1

  • 1From the Division of Hematology/Oncology, Scripps Clinic, La Jolla, CA; Providence Oncology and Hematology Care, Providence Cancer Center, Portland, OR; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA.

American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|May 21, 2015
PubMed
Summary
This summary is machine-generated.

Oncology practice is evolving due to complex knowledge and patient involvement. This review examines changes in practice patterns, team-based care, and the integration of advanced practitioners like physician assistants and nurse practitioners.

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.9K
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

6.0K

Related Experiment Videos

Last Updated: Apr 12, 2026

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

2.1K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.9K
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

6.0K

Area of Science:

  • Oncology
  • Health Services Research
  • Medical Practice Management

Background:

  • Oncology practice is increasingly complex, driven by knowledge expansion and evolving patient engagement.
  • Traditional practice models may no longer be efficient.
  • The need for adaptive strategies in cancer care delivery is evident.

Purpose of the Study:

  • To review key changes impacting clinical oncology practice.
  • To explore strategies for enhancing efficiency and quality in cancer care.
  • To identify optimal integration models and barriers for advanced practitioners in oncology teams.

Main Methods:

  • Review of the American Society of Clinical Oncology (ASCO) National Oncology Census data.
  • Analysis of the National Cancer Institute (NCI)-ASCO Teams in Cancer Care Project findings.
  • Examination of literature on physician assistant (PA) and nurse practitioner (NP) integration in oncology.

Main Results:

  • The ASCO National Oncology Census provides insights into the U.S. oncology workforce and perceived practice shifts.
  • The NCI-ASCO Teams in Cancer Care Project highlights the potential of team science for improving cancer care delivery.
  • Identified barriers and potential strategies for integrating PAs and NPs into oncology teams.

Conclusions:

  • Oncology practice requires adaptation to increasing complexity and demands.
  • Team-based care models, leveraging team science, are crucial for efficient and high-quality cancer care.
  • Effective integration of physician assistants and nurse practitioners can address workforce challenges and improve patient outcomes.